Patents by Inventor Irina Baltcheva

Irina Baltcheva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using factor B inhibitors
    Patent number: 11951101
    Abstract: Described herein are methods of treating paroxysmal nocturnal hemoglobinuria (PNH) with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, e.g. LNP023 hydrochloride.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: April 9, 2024
    Assignee: Novartis AG
    Inventors: Irina Baltcheva, Peter End, Julie Marie-Pomme Gabrielle Milojevic
  • TREATMENT FOR SJÖGREN'S SYNDROME
    Publication number: 20220356261
    Abstract: The present disclosure relates to methods for treating Sjögren's Syndrome disease using therapeutically effective doses of anti-BAFFR antibody, such as ianalumab.
    Type: Application
    Filed: October 23, 2020
    Publication date: November 10, 2022
    Inventors: Irina BALTCHEVA, Wolfgang HUEBER, Stephen OLIVER, Olivier PETRICOUL
  • METHODS OF USING FACTOR B INHIBITORS
    Publication number: 20220016103
    Abstract: Described herein are methods of treating paroxysmal nocturnal hemoglobinuria (PNH) with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, e.g. LNP023 hydrochloride.
    Type: Application
    Filed: July 15, 2021
    Publication date: January 20, 2022
    Inventors: Irina BALTCHEVA, Peter END, Julie Marie-Pomme Gabrielle MILOJEVIC
  • TESIDOLUMAB FOR USE IN THE TREATMENT OF TRANSPLANT REJECTION
    Publication number: 20190225679
    Abstract: The present invention relates to the use of tesidolumab for the prevention or treatment of transplant rejection and in particular antibody mediated rejection of allografts.
    Type: Application
    Filed: June 5, 2017
    Publication date: July 25, 2019
    Inventors: Florian Muellershausen, Matthias Meier, Alan Slade, Irina Baltcheva, Mark Milton
  • AN ANTI-C5 ANTIBODY DOSING REGIMEN
    Publication number: 20190127453
    Abstract: The present invention relates to the use of an anti-C5 antibody or binding fragment thereof for the treatment of transplant rejection and in particular antibody mediated rejection of allografts.
    Type: Application
    Filed: June 5, 2017
    Publication date: May 2, 2019
    Inventors: Florian Muellershausen, Matthias Meier, Alan Slade, Irina Baltcheva, Mark Milton